Who wants to win or lose on Health-Care Stocks? The Sirtex (SRX) saga draws to an end.

https://technicality.me/2016/12/19/chart-review-sirtex-srx/

SRX Jan 18

There is, it would seem, a happy ending for disgruntled shareholders of beleaguered health-care stock Sirtex.

After all the to-ing and fro-ing, the cash offer of $28 per share from global healthcare stock Varian Medical Systems, is a great outcome. Some investors may have doubled their money within the month.



Categories: Company review

Tags:

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

w

Connecting to %s

%d bloggers like this: